At the news
? NEUTRALIMPACT 4/10 CLUSTER filed Mar 16, 2026 at 16:31 ET
Multiple United Therapeutics insiders, including CEO Martine Rothblatt and CFO James Edgemond, engaged in significant stock transactions over the past week, primarily involving derivative exercises and tax-related share withholdings. The open-market sales totaled $684,416, while non-cash transactions (exercises and tax withholdings) amounted to over $10.1 million in value. This cluster reflects routine equity settlement activity rather than strategic selling.
- CEO Martine Rothblatt sold 1,009 shares for $537,803 across three open-market transactions; also exercised derivatives on 61,499 shares at $146.03 strike price
- CFO James Edgemond had $2.51M in tax withholding (F transaction) and exercised derivatives on 10,380 shares (non-cash)
- COO Michael Benkowitz had $4.20M in tax withholding (F transaction)
- EVP Paul Mahon sold 753 shares for $397,184 and exercised derivatives on 17,195 shares
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access